Hypoglycemia is defined asplasma glucose level sufficiently low to result in neurological damage. In the new-born age, the incidence of hypoglycemia ranges from 0.4-11.4%. Etiologically, low levels of plasma glucose can result from the hormonal or metabolic disorders; high doses of insulin, drug poisoning, liver disease or systemic disorders. The most common cause of severe and permanent hypoglycemia in the neonatal age group is congenital hyperinsulinism - the result of pancreatic cells hyperplasia and/or adenoma. Between two and five years of age, the most common form of hypoglycemic state is ketotic hypoglycemia of childhood, caused by limited amount of substrate. Diagnostic criteria include biochemical confirmation of low of glucose and/or high insulin levels, blood hormone testing (epinephrine, cortisol, growth hormone, glucagon levels), as well as metabolic screeningfor gluconeogenesis, glycogenolysis, and lipolysis disorders and disarrangements of fatty acid oxidation. Therapy is directed towards the substrate supplementation and the application of medications and fuels aiming atrapid attainment of normoglycemia (fruit juices, parenterally applied glucose and dextrose, glucagone, corticosteroid therapy); diazoxide and somatostatin therapy is indicated for patients with hyperinsulinemia.
SENIOR B, SADEGHI‐NEJAD A. Hypoglycemia: A pathophysiologic approach. Acta Paediatrica. 1989;78(s352):1–27.
2.
Arnoux JB, Verkarre V, Saint-Martin C, Montravers F, Brassier A, Valayannopoulos V, et al. Congenital hyperinsulinism: current trends in diagnosis and therapy. Orphanet Journal of Rare Diseases. 2011;6(1).
3.
Hardy OT, Hernandez-Pampaloni M, Saffer JR, Scheuermann JS, Ernst LM, Freifelder R, et al. Accuracy of [18F]Fluorodopa Positron Emission Tomography for Diagnosing and Localizing Focal Congenital Hyperinsulinism. The Journal of Clinical Endocrinology & Metabolism. 2007;92(12):4706–11.
4.
Huypens P, Ling Z, Pipeleers D, Schuit F. Glucagon receptors on human islet cells contribute to glucose competence of insulin release. Diabetologia. 2000;43(8):1012–9.
5.
Panten U, Burgfeld J, Goerke F, Rennicke M, Schwanstecher M, Wallasch A, et al. Control of insulin secretion by sulfonylureas, meglitinide and diazoxide in relation to their binding to the sulfonylurea receptor in pancreatic islets. Biochemical Pharmacology. 1989;38(8):1217–29.
6.
Yildizdas D, Erdem S, Küçükosmanoǧlu O, Yilmaz M, Yüksel B. Pulmonary hypertension, heart failure and neutropenia due to diazoxide therapy. Advances in Therapy. 2008;25(5):515–9.
7.
de Lonlay-Debeney P, Poggi-Travert F, Fournet JC, Sempoux C, Vici CD, Brunelle F, et al. Clinical Features of 52 Neonates with Hyperinsulinism. New England Journal of Medicine. 1999;340(15):1169–75.
8.
Touati G, Poggi-Travert F, Ogier de Baulny H, Rahier J, Brunelle F, Nihoul-Fekete C, et al. Long-term treatment of persistent hyperinsulinaemic hypoglycaemia of infancy with diazoxide: a retrospective review of 77 cases and analysis of efficacy-predicting criteria. European Journal of Pediatrics. 1998;157(8):628–33.
9.
Yadav1 S, Nigwekar P. 2013;2(ue 4).
10.
Gold AE, Deary IJ, Frier BM. Recurrent Severe Hypoglycaemia and Cognitive Function in Type 1 Diabetes. Diabetic Medicine. 1993;10(6):503–8.
11.
Jovanović A, Marković-Jovanović S, Perić V, Stolić R. Distinictive Characteristics and Specific Management of Diabetic Ketoacidosis in Patients with Acute Myocardial Infarction, Stroke and Renal Failure.
12.
Priyambada L. Indian Journal of Emergency Pediatrics. (Idiopathic) Ketotic hypoglycemia in children. 2009;1(2).
13.
Richard B, Robert K, Hal J. Udžbenik Pedijatrije, Poremećaj metabolizma ugljenih hidrata. 2008;505–17.
14.
Kochar IS, Hussain K. From hyperinsulinaemic hypoglycaemia to ketotic hypoglycaemia: the range of glucose abnormalities in patients born with intrauterine growth retardation. European Journal of Pediatrics. 2007;166(10):1003–7.
15.
Jovanovic A, Stolic R, Markovic Jovanovic S, Rasic D, Peric V. Stroke and diabetic ketoacidosis – some diagnostic and therapeutic considerations. Vascular Health and Risk Management. :201.
16.
Markovic- S. Nutritional Management in Type 1 Diabetes Mellitus. Type 1 Diabetes.
17.
C.A S. Miriam Ciljakova, Milos Jesenak, Miroslava Brndiarova and Peter Banovcin Management Approach to Hypoglycemia; Diabetes - Damages and Treatments,2011. 2006;
18.
D. L. Pediatric Endocrinology, Chapter 11, Hypoglycemia in the infant and child. :442–50.
19.
Pinney SE, MacMullen C, Becker S, Lin YW, Hanna C, Thornton P, et al. Clinical characteristics and biochemical mechanisms of congenital hyperinsulinism associated with dominant KATP channel mutations. Journal of Clinical Investigation. 2008;118(8):2877–86.
20.
Hoe FM. Hypoglycemia in Infants and Children. Advances in Pediatrics. 2008;55(1):367–84.
21.
Felter RA, Waldrop RD. Hypoglycemia in Infants and Children.
22.
G.D G, D S. Greenspans basic & clinical Endocrinology; Hypoglicemic Disorders, 19 Chapner. :748–70.
23.
Marković-Jovanović SR, Stolić RV, Jovanović AN. The reliability of body mass index in the diagnosis of obesity and metabolic risk in children. Journal of Pediatric Endocrinology and Metabolism. 2015;28(5–6).
24.
A. AG, G S. Hypoglycaemia in infancy and childhood. 1985;29.
25.
DUNNE MJ, COSGROVE KE, SHEPHERD RM, AYNSLEY-GREEN A, LINDLEY KJ. Hyperinsulinism in Infancy: From Basic Science to Clinical Disease. Physiological Reviews. 2004;84(1):239–75.
26.
Otonkoski T, Kaminen N, Ustinov J, Lapatto R, Meissner T, Mayatepek E, et al. Physical Exercise-Induced Hyperinsulinemic Hypoglycemia Is an Autosomal-Dominant Trait Characterized by Abnormal Pyruvate-Induced Insulin Release. Diabetes. 2003;52(1):199–204.
27.
Højlund K, Hansen T, Lajer M, Henriksen JE, Levin K, Lindholm J, et al. A Novel Syndrome of Autosomal-Dominant Hyperinsulinemic Hypoglycemia Linked to a Mutation in the Human Insulin Receptor Gene. Diabetes. 2004;53(6):1592–8.
28.
Cryer PE, Axelrod L, Grossman AB, Heller SR, Montori VM, Seaquist ER, et al. Evaluation and Management of Adult Hypoglycemic Disorders: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology & Metabolism. 2009;94(3):709–28.
29.
Hyperinsulinism C, Gillespie RS, Kemp S.
30.
Wolfsdorf JI. Hyperinsulinemic hypoglycemia of infancy. The Journal of Pediatrics. 1998;132(1):1–3.
31.
Clayton PT, Eaton S, Aynsley-Green A, Edginton M, Hussain K, Krywawych S, et al. Hyperinsulinism in short-chain L-3-hydroxyacyl-CoA dehydrogenase deficiency reveals the importance of β-oxidation in insulin secretion. Journal of Clinical Investigation. 2001;108(3):457–65.
32.
Dragan ZS. Klinička pedijatrijska endokrinologija XIV poglavlje: metabolizam ugljenih hidrata i hipoglikemija. 2000;481-514,.
33.
Cryer PE. Glucosae homeostasis. In 1992.
34.
Halamek LP, Stevenson DK. Neonatal Hypoglycemia, Part II: Pathophysiology and Therapy. Clinical Pediatrics. 1998;37(1):11–6.
35.
Sood A, Grover N, Sharma R. Biochemical abnormalities in neonatal seizures. The Indian Journal of Pediatrics. 2003;70(3):221–4.
36.
Snežana MJ, M. P, D. O, A J. Vrednosti magnezijuma, cinka i hroma u gojazne dece I njihova povezanost sa distribucijom potkožnog masnog tkiva I sekrecijom insulin. 2012;40:1-2 11-16.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
